Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease

Biology of Blood and Marrow Transplantation

Volumn 11, Issue 7, 2005, Pages 567-568

  Sorror, Mohamed L ^a   Leisenring, Wendy ^a,b   Deeg, H Joachim ^a,c   Martin, Paul J ^a,c   Storb, Rainer ^a,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b Schools of Medicine and Public Health   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ASPERGILLOSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRONCHOPNEUMONIA; CAUSE OF DEATH; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HLA MATCHING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; JAW CANCER; KIDNEY FAILURE; LETTER; LIVER FAILURE; LUNG INSUFFICIENCY; MORTALITY; MULTIPLE ORGAN FAILURE; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SEPSIS; SEPTIC SHOCK; SUDDEN DEATH; SURVIVAL RATE; TREATMENT OUTCOME;

ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE;

EID: 20844447561     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2005.03.004     Document Type: Letter

References (3)

1. R. Storb H.J. Deeg V. Farewell et al. Marrow transplantation for severe aplastic anemia: Methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease Blood 68 1986 119-125
2. R. Storb H.J. Deeg M. Pepe et al. Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: Long-term follow-up of a controlled trial Br J Haematol. 72 1989 567-572
3. M.S. Pepe G. Longton M. Pettinger M. Mori L.D. Fisher R. Storb Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: Motivation for and description of new methods Br J Haematol. 83 1993 602-607